Cargando…

Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk

INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesench...

Descripción completa

Detalles Bibliográficos
Autores principales: Widjaja, Sri Lilidjanti, Salimo, Harsono, Yulianto, Indah, Soetrisno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324926/
https://www.ncbi.nlm.nih.gov/pubmed/34354424
http://dx.doi.org/10.1016/j.sjbs.2021.04.034
_version_ 1783731461974654976
author Widjaja, Sri Lilidjanti
Salimo, Harsono
Yulianto, Indah
Soetrisno
author_facet Widjaja, Sri Lilidjanti
Salimo, Harsono
Yulianto, Indah
Soetrisno
author_sort Widjaja, Sri Lilidjanti
collection PubMed
description INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesenchymal stem cells from breastmilk can be an alternative source of stem cells that can potentially affect cardiovascular therapy. This study aimed to identify the proteomic analysis of secretome mesenchymal stem-like cells under hypoxia compared to non-hypoxia from human breastmilk stem cells. MATERIAL AND METHODS: The human breastmilk was collected from six healthy breastfeeding women and transported to the laboratory under aseptic conditions. The breastmilk cells were isolated then cultured. After 72 h, the human breastmilk stem cells reached confluence then cleaned up and isolated in serum-free media (spheroid) to allow serial passaging every 48 h. The acquisition stem cell was made with flow cytometry. The cells were divided into hBSC secretomes under hypoxia (A) and non-hypoxia (B) and analyzed for LC-MS to identify the peptide structure. RESULTS: The human breastmilk cells contained several mesenchymal stem-like cells in density 2.4 × 10(6) cell/mL for hypoxia and 2 × 10(6) cell/mL for non-hypoxia conditions. The human breastmilk stem cell surface markers derived from the third cell passage process were 93.77% for CD44, 98.69% for CD73, 88.45% for CD90, and 96.30% for CD105. The protein level of secretome mesenchymal stem -like cells under hypoxia was measured at 5.56 μg/mL and 4.28 μg/mL for non-hypoxia. The liquid chromatography-mass spectrometry analysis identified 130 and 59 peptides from hypoxia and non-hypoxia of the human breastmilk stem cell secretome sequentially. Some important proteomics structures were found in the hypoxic human breastmilk stem cell secretome, such as transforming growth factor-β, VE-cadherin, and caspase. CONCLUSION: The human breastmilk cells contain mesenchymal stem-like cells and a high concentration of CD44, CD73, CD90, and CD105 as surface markers at third passage culture. The hypoxic hBSC secretome produces a higher protein level compare to non-hypoxia. The transforming growth factor -β was found in the hypoxic hBSC secretome as a modulator of VEGF-mediated angiogenesis.
format Online
Article
Text
id pubmed-8324926
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83249262021-08-04 Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk Widjaja, Sri Lilidjanti Salimo, Harsono Yulianto, Indah Soetrisno Saudi J Biol Sci Original Article INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesenchymal stem cells from breastmilk can be an alternative source of stem cells that can potentially affect cardiovascular therapy. This study aimed to identify the proteomic analysis of secretome mesenchymal stem-like cells under hypoxia compared to non-hypoxia from human breastmilk stem cells. MATERIAL AND METHODS: The human breastmilk was collected from six healthy breastfeeding women and transported to the laboratory under aseptic conditions. The breastmilk cells were isolated then cultured. After 72 h, the human breastmilk stem cells reached confluence then cleaned up and isolated in serum-free media (spheroid) to allow serial passaging every 48 h. The acquisition stem cell was made with flow cytometry. The cells were divided into hBSC secretomes under hypoxia (A) and non-hypoxia (B) and analyzed for LC-MS to identify the peptide structure. RESULTS: The human breastmilk cells contained several mesenchymal stem-like cells in density 2.4 × 10(6) cell/mL for hypoxia and 2 × 10(6) cell/mL for non-hypoxia conditions. The human breastmilk stem cell surface markers derived from the third cell passage process were 93.77% for CD44, 98.69% for CD73, 88.45% for CD90, and 96.30% for CD105. The protein level of secretome mesenchymal stem -like cells under hypoxia was measured at 5.56 μg/mL and 4.28 μg/mL for non-hypoxia. The liquid chromatography-mass spectrometry analysis identified 130 and 59 peptides from hypoxia and non-hypoxia of the human breastmilk stem cell secretome sequentially. Some important proteomics structures were found in the hypoxic human breastmilk stem cell secretome, such as transforming growth factor-β, VE-cadherin, and caspase. CONCLUSION: The human breastmilk cells contain mesenchymal stem-like cells and a high concentration of CD44, CD73, CD90, and CD105 as surface markers at third passage culture. The hypoxic hBSC secretome produces a higher protein level compare to non-hypoxia. The transforming growth factor -β was found in the hypoxic hBSC secretome as a modulator of VEGF-mediated angiogenesis. Elsevier 2021-08 2021-04-20 /pmc/articles/PMC8324926/ /pubmed/34354424 http://dx.doi.org/10.1016/j.sjbs.2021.04.034 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Widjaja, Sri Lilidjanti
Salimo, Harsono
Yulianto, Indah
Soetrisno
Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title_full Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title_fullStr Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title_full_unstemmed Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title_short Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
title_sort proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324926/
https://www.ncbi.nlm.nih.gov/pubmed/34354424
http://dx.doi.org/10.1016/j.sjbs.2021.04.034
work_keys_str_mv AT widjajasrililidjanti proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk
AT salimoharsono proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk
AT yuliantoindah proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk
AT soetrisno proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk